Advertisement

Topics

Search Results for "Abbott Dartford Murex Biotech Ltd"

18:26 EDT 28th June 2016 | BioPortfolio

Matching Channels

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Abbott to Acquire Alere for 5.8B

Abbott has announced a definitive agreement to acquire Alere, significantly advancing Abbott’s global diagnostics presence and leadership. Abbott will pay $56 per common share at a total expecte...

Beijing Strong Biotech Grants Technology License to Abbott

Beijing Strong Biotechnologies (BSBE) recently signed a technology license granting Abbott Labs rights to its clinical chemistry testing products, which BSBE currently manufactures in China. Initially...

Abbott to Gain Leadership in POC Diagnostics upon Acquisition of Alere

Abbott and Alere have reached a definitive agreement under which Abbott will pay an equity value of about USD 5.8...

Abbott enters systems integration deal with Diasend

A collaboration deal has been reached by Abbott and Diasend to allow a cloud-based connection between Abbott's LibreLink syst -More- 

Abbott Laboratories will Diagnostik-Spezialisten Alere schlucken

ABBOTT PARK (dpa-AFX) - Der US-Pharmakonzern Abbott Laboratories will seine Diagnostiksparte mit einem Milliardenzukauf verstärken. Für den kleineren Wettbewerber Alere bietet der Konzern 56 US-Do.....

Abbott deal for St. Jude spurs company split talk

When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Mil...

Abbott Issues 2016 Earnings Outlook

NORTH CHICAGO (dpa-AFX) - Abbott (ABT) announced the company expects full-year 2016 earnings per share, excluding specified items, in the range of $2.10 to $2.20. Abbott's 2016 forecast assumes a ...

Abbott buys diagnostics company Alere

Abbott Laboratories (NYSE:ABT) is acquiring diagnostics play Alere Inc. (NYSE:ALR) for $56 per share in cash, or about $5.8 billion. Abbott said it will assume or refinance Alere's net debt of $2.6 bi...

Matching PubMed Articles

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015...

Erratum: When biotech goes bad.

First-quarter biotech job picture.

Fresh from the biotech pipeline-2015.

UK biotech smashes financing record.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement